Pat Roberts said...

One new requirement under the Cures Act is for manufacturers of an investigational drug to make its policies on evaluati...

We are in a dire fix. We are trying to write a farm bill here, and it is with a backdrop of severe budget limitations.

Sooner than later.

I have the honor of introducing C.J. Mahoney, the nominee to be a Deputy United States Trade Representative.